Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley JF, Gorin NC, Szer J, Bradstock K, Buzyn A, Clark P, Borkett K, Gratwohl A; European Group for Blood and Marrow Transplantation. Schmitz N, et al. Among authors: borkett k. Blood. 2002 Aug 1;100(3):761-7. doi: 10.1182/blood-2001-12-0304. Blood. 2002. PMID: 12130483 Free article. Clinical Trial.
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, Bourquelot P, Greinix H, Frickhofen N, Ringdén O, Zander A, Apperley JF, Gorin C, Borkett K, Schwab G, Goebel M, Russell NH, Gratwohl A. Schmitz N, et al. Among authors: borkett k. Bone Marrow Transplant. 1998 May;21(10):995-1003. doi: 10.1038/sj.bmt.1701234. Bone Marrow Transplant. 1998. PMID: 9632272 Clinical Trial.
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.
Kottaridis PD, Peggs K, Schmitz N, Dreger P, Boogaerts MA, Ferrant A, Demuynck HM, Zander A, Link H, Matcham J, Linch DC, Borkett K, Goldstone AH. Kottaridis PD, et al. Among authors: borkett k. Leuk Lymphoma. 2002 Mar;43(3):531-6. doi: 10.1080/10428190290012010. Leuk Lymphoma. 2002. PMID: 12002756 Clinical Trial.
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. Antonik LJ, et al. Among authors: borkett km. Anesth Analg. 2012 Aug;115(2):274-83. doi: 10.1213/ANE.0b013e31823f0c28. Epub 2011 Dec 20. Anesth Analg. 2012. PMID: 22190555 Clinical Trial.
Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users.
Schippers F, Pesic M, Saunders R, Borkett K, Searle S, Webster L, Stoehr T. Schippers F, et al. Among authors: borkett k. J Clin Pharmacol. 2020 Sep;60(9):1189-1197. doi: 10.1002/jcph.1614. Epub 2020 Jun 3. J Clin Pharmacol. 2020. PMID: 32495449 Free PMC article. Clinical Trial.
12 results